Heartsciences Inc. (HSCS) — SEC Filings
Heartsciences Inc. (HSCS) — 1 SEC filings. Latest: QUALIF (Apr 20, 2026). Includes 1 QUALIF.
View Heartsciences Inc. on SEC EDGAR
Overview
Heartsciences Inc. (HSCS) is a publicly traded company with 1 SEC filings tracked on ReadTheFiling.
Sentiment Summary
Across 1 filings, the sentiment breakdown is: 1 neutral. The dominant filing sentiment for Heartsciences Inc. is neutral.
Filing Type Overview
Heartsciences Inc. (HSCS) has filed 1 QUALIF with the SEC between Apr 2026.
Recent SEC Filings (1)
| Date | Form | Description | Risk |
|---|---|---|---|
| Apr 20, 2026 | QUALIF | QUALIF Filing |
Frequently Asked Questions
What are the latest SEC filings for Heartsciences Inc. (HSCS)?
Heartsciences Inc. has 1 recent SEC filings from Apr 2026, including 1 QUALIF. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of HSCS filings?
Across 1 filings, the sentiment breakdown is: 1 neutral. The dominant sentiment is neutral.
Where can I find Heartsciences Inc. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Heartsciences Inc. (HSCS) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Heartsciences Inc.?
Financial highlights for Heartsciences Inc. are available when 10-K or 10-Q filings are enriched with AI analysis. Check back as new filings are processed.
What is the investment thesis for HSCS?
Investment thesis data for HSCS will be available once enriched filings are processed.
Who are the key executives at Heartsciences Inc.?
Executive information for Heartsciences Inc. is extracted from SEC filings as they are enriched with AI analysis.
What are the main risk factors for Heartsciences Inc. stock?
Risk factor analysis for Heartsciences Inc. is available when filings are enriched with AI risk assessment.
What are recent predictions and forward guidance from Heartsciences Inc.?
Forward guidance and predictions for Heartsciences Inc. are extracted from SEC filings as they are enriched.